Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Apr;63(4):1473–1477. doi: 10.1128/iai.63.4.1473-1477.1995

Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice.

R Faggioni 1, G Fantuzzi 1, P Villa 1, W Buurman 1, L J van Tits 1, P Ghezzi 1
PMCID: PMC173177  PMID: 7890412

Abstract

Lipopolysaccharide (LPS) induces a variety of central and peripheral effects that are largely mediated by cytokines, including tumor necrosis factor (TNF). Peripheral (intravenous [i.v.]) administration of LPS (2.5 micrograms per mouse) induced TNF levels in the serum and spleen but not in the brain, while central (intracerebroventricular [i.c.v.]) administration of LPS induced TNF production both in the brain and in the periphery. Mice challenged with LPS after LPS pretreatment (35 micrograms per mouse, intraperitoneally, as a single dose on day -3 or as a 4-day treatment on days -5 to -2) were unresponsive in terms of induction of serum TNF. When peripherally LPS-tolerant mice (where LPS pretreatment was given intraperitoneally) were challenged with an i.c.v. dose of LPS, brain (but not serum) TNF was still produced, meaning that the LPS-tolerant state was confined to the periphery. However, if LPS pretreatment was given i.c.v. (35 micrograms, as a single dose), the brain, like the periphery, became LPS tolerant in terms of TNF production. We investigated how tolerance to LPS affected two of its actions, decrease in food intake and induction of serum corticosterone (CS). After an i.v. challenge in peripherally LPS-tolerant mice, no decrease in food intake was observed, but this response was still elicited by an i.c.v. challenge. LPS tolerance reduced the CS response to i.v. and i.c.v. challenge. These results suggest that LPS-induced decrease in food intake might be a fully central effect, while the increase of serum CS might be due to both central and peripheral actions.

Full Text

The Full Text of this article is available as a PDF (188.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggarwal B. B., Kohr W. J., Hass P. E., Moffat B., Spencer S. A., Henzel W. J., Bringman T. S., Nedwin G. E., Goeddel D. V., Harkins R. N. Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem. 1985 Feb 25;260(4):2345–2354. [PubMed] [Google Scholar]
  2. Ayala A., Kisala J. M., Felt J. A., Perrin M. M., Chaudry I. H. Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis? Arch Surg. 1992 Feb;127(2):191–197. doi: 10.1001/archsurg.1992.01420020077011. [DOI] [PubMed] [Google Scholar]
  3. Bernton E. W., Beach J. E., Holaday J. W., Smallridge R. C., Fein H. G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science. 1987 Oct 23;238(4826):519–521. doi: 10.1126/science.2821620. [DOI] [PubMed] [Google Scholar]
  4. Bodnar R. J., Pasternak G. W., Mann P. E., Paul D., Warren R., Donner D. B. Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat. Cancer Res. 1989 Nov 15;49(22):6280–6284. [PubMed] [Google Scholar]
  5. Breder C. D., Tsujimoto M., Terano Y., Scott D. W., Saper C. B. Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system. J Comp Neurol. 1993 Nov 22;337(4):543–567. doi: 10.1002/cne.903370403. [DOI] [PubMed] [Google Scholar]
  6. Darling G., Goldstein D. S., Stull R., Gorschboth C. M., Norton J. A. Tumor necrosis factor: immune endocrine interaction. Surgery. 1989 Dec;106(6):1155–1160. [PubMed] [Google Scholar]
  7. De Simoni M. G., Sironi M., De Luigi A., Manfridi A., Mantovani A., Ghezzi P. Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6. J Exp Med. 1990 May 1;171(5):1773–1778. doi: 10.1084/jem.171.5.1773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dentener M. A., Greve J. W., Maessen J. G., Buurman W. A. Role of tumour necrosis factor in the enhanced sensitivity of mice to endotoxin after exposure to lead. Immunopharmacol Immunotoxicol. 1989;11(2-3):321–334. doi: 10.3109/08923978909005373. [DOI] [PubMed] [Google Scholar]
  9. Fraker D. L., Stovroff M. C., Merino M. J., Norton J. A. Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med. 1988 Jul 1;168(1):95–105. doi: 10.1084/jem.168.1.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gomez-Sanchez C., Murry B. A., Kem D. C., Kaplan N. M. A direct radioimmunoassay of corticosterone in rat serum. Endocrinology. 1975 Mar;96(3):796–798. doi: 10.1210/endo-96-3-796. [DOI] [PubMed] [Google Scholar]
  11. Gottschall P. E., Koves K., Mizuno K., Tatsuno I., Arimura A. Glucocorticoid upregulation of interleukin 1 receptor expression in a glioblastoma cell line. Am J Physiol. 1991 Sep;261(3 Pt 1):E362–E368. doi: 10.1152/ajpendo.1991.261.3.E362. [DOI] [PubMed] [Google Scholar]
  12. Henricson B. E., Benjamin W. R., Vogel S. N. Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance. Infect Immun. 1990 Aug;58(8):2429–2437. doi: 10.1128/iai.58.8.2429-2437.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Houssiau F. A., Bukasa K., Sindic C. J., Van Damme J., Van Snick J. Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin Exp Immunol. 1988 Feb;71(2):320–323. [PMC free article] [PubMed] [Google Scholar]
  14. Leist T. P., Frei K., Kam-Hansen S., Zinkernagel R. M., Fontana A. Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients. J Exp Med. 1988 May 1;167(5):1743–1748. doi: 10.1084/jem.167.5.1743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Malarkey W. B., Zvara B. J. Interleukin-1 beta and other cytokines stimulate adrenocorticotropin release from cultured pituitary cells of patients with Cushing's disease. J Clin Endocrinol Metab. 1989 Jul;69(1):196–199. doi: 10.1210/jcem-69-1-196. [DOI] [PubMed] [Google Scholar]
  16. Mefford I. N., Masters C. F., Heyes M. P., Eskay R. L. Cytokine-induced activation of the neuroendocrine stress axis persists in endotoxin-tolerant mice. Brain Res. 1991 Aug 23;557(1-2):327–330. doi: 10.1016/0006-8993(91)90154-n. [DOI] [PubMed] [Google Scholar]
  17. Mengozzi M., Ghezzi P. Cytokine down-regulation in endotoxin tolerance. Eur Cytokine Netw. 1993 Mar-Apr;4(2):89–98. [PubMed] [Google Scholar]
  18. Mengozzi M., Sironi M., Gadina M., Ghezzi P. Reversal of defective IL-6 production in lipopolysaccharide-tolerant mice by phorbol myristate acetate. J Immunol. 1991 Aug 1;147(3):899–902. [PubMed] [Google Scholar]
  19. Mustafa M. M., Ramilo O., Sáez-Llorens X., Olsen K. D., Magness R. R., McCracken G. H., Jr Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child. 1990 Aug;144(8):883–887. doi: 10.1001/archpedi.1990.02150320047024. [DOI] [PubMed] [Google Scholar]
  20. Plata-Salamán C. R., Oomura Y., Kai Y. Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system. Brain Res. 1988 May 10;448(1):106–114. doi: 10.1016/0006-8993(88)91106-7. [DOI] [PubMed] [Google Scholar]
  21. Ruddle N. H., Bergman C. M., McGrath K. M., Lingenheld E. G., Grunnet M. L., Padula S. J., Clark R. B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med. 1990 Oct 1;172(4):1193–1200. doi: 10.1084/jem.172.4.1193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rusconi F., Parizzi F., Garlaschi L., Assael B. M., Sironi M., Ghezzi P., Mantovani A. Interleukin 6 activity in infants and children with bacterial meningitis. The Collaborative Study on Meningitis. Pediatr Infect Dis J. 1991 Feb;10(2):117–121. doi: 10.1097/00006454-199102000-00008. [DOI] [PubMed] [Google Scholar]
  23. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 1987 Oct 23;238(4826):522–524. doi: 10.1126/science.2821621. [DOI] [PubMed] [Google Scholar]
  24. Saukkonen K., Sande S., Cioffe C., Wolpe S., Sherry B., Cerami A., Tuomanen E. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med. 1990 Feb 1;171(2):439–448. doi: 10.1084/jem.171.2.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tominaga T., Fukata J., Naito Y., Usui T., Murakami N., Fukushima M., Nakai Y., Hirai Y., Imura H. Prostaglandin-dependent in vitro stimulation of adrenocortical steroidogenesis by interleukins. Endocrinology. 1991 Jan;128(1):526–531. doi: 10.1210/endo-128-1-526. [DOI] [PubMed] [Google Scholar]
  26. Tsagarakis S., Gillies G., Rees L. H., Besser M., Grossman A. Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus. Neuroendocrinology. 1989 Jan;49(1):98–101. doi: 10.1159/000125096. [DOI] [PubMed] [Google Scholar]
  27. Waage A., Halstensen A., Shalaby R., Brandtzaeg P., Kierulf P., Espevik T. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med. 1989 Dec 1;170(6):1859–1867. doi: 10.1084/jem.170.6.1859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wispelwey B., Lesse A. J., Hansen E. J., Scheld W. M. Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. J Clin Invest. 1988 Oct;82(4):1339–1346. doi: 10.1172/JCI113736. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES